Teleflex Incorporated
General ticker "TFX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $6.3B (TTM average)
Teleflex Incorporated does not follow the US Stock Market performance with the rate: -1.3%.
Estimated limits based on current volatility of 2.0%: low 101.79$, high 106.46$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-14, amount 0.34$ (Y1.32%)
- Total employees count: 14100 (-2.8%) as of 2024
- US accounted for 62.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Economic downturns and volatility, Market risk, ERP system disruptions, Sterilization issues
- Current price 34.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [153.71$, 221.45$]
- 2025-12-31 to 2026-12-31 estimated range: [157.86$, 226.05$]
Financial Metrics affecting the TFX estimates:
- Negative: with PPE of 12.7 at the end of fiscal year the price was high
- Positive: -5.02 < Operating profit margin, % of 5.18
- Positive: 42.53 < Shareholder equity ratio, % of 60.27 <= 64.17
- Positive: 6.63 < Operating cash flow per share per price, % of 7.66
- Negative: 0.74 < Interest expense per share per price, % of 1.01
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Investing cash flow per share per price, % of -1.20 <= -0.62
Short-term TFX quotes
Long-term TFX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,797.55MM | $2,933.69MM | $2,914.59MM |
| Operating Expenses | $2,297.82MM | $2,427.38MM | $2,763.58MM |
| Operating Income | $499.73MM | $506.31MM | $151.01MM |
| Non-Operating Income | $-53.81MM | $-72.30MM | $-75.53MM |
| Interest Expense | $54.26MM | $85.08MM | $83.54MM |
| R&D Expense | $153.82MM | $154.35MM | $161.67MM |
| Income(Loss) | $445.92MM | $434.01MM | $75.48MM |
| Taxes | $83.00MM | $76.44MM | $5.32MM |
| Other Income(Loss) | $0.22MM | $-1.24MM | $-0.49MM |
| Profit(Loss)* | $363.36MM | $355.08MM | $69.19MM |
| Stockholders Equity | $4,021.97MM | $4,440.99MM | $4,278.14MM |
| Inventory | $578.51MM | $626.22MM | $600.13MM |
| Assets | $6,928.06MM | $7,532.55MM | $7,097.91MM |
| Operating Cash Flow | $342.14MM | $510.64MM | $635.74MM |
| Capital expenditure | $79.19MM | $91.44MM | $126.43MM |
| Investing Cash Flow | $-257.94MM | $-621.23MM | $-99.36MM |
| Financing Cash Flow | $-217.51MM | $38.54MM | $-421.93MM |
| Earnings Per Share** | $7.75 | $7.56 | $1.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.